Clinical approach to splanchnic vein thrombosis: Risk factors and treatment

Thrombosis Research

Volumn 130, Issue SUPPL.1, 2012, Pages S1-

  Riva, Nicoletta ^a   Donadini, Marco P ^a   Dentali, Francesco ^a   Squizzato, Alessandro ^a   Ageno, Walter ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Anticoagulant therapy; Risk factors; Splanchnic vein thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; HEPARIN; JANUS KINASE 2; LOW MOLECULAR WEIGHT HEPARIN;

ABDOMINAL CANCER; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL HEMORRHAGE; HORMONAL THERAPY; HUMAN; LIVER CIRRHOSIS; LIVER VEIN THROMBOSIS; MESENTERIC VEIN THROMBOSIS; MYELOPROLIFERATIVE DISORDER; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PORTAL VEIN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK FACTOR; SPLANCHNIC VEIN THROMBOSIS; SPLENIC VEIN; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 84866981369     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.08.259     Document Type: Article

References (26)

1. T.P. Almdal, and T.I. Sorensen Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry data. The Danish Association for the Study of the Liver Hepatology 13 1991 650 655
2. M. Ögren, D. Bergqvist, M. Björck, S. Acosta, H. Eriksson, and N.H. Sternby Portal vein thrombosis: Prevalence, patient characteristics and lifetime risk: A population study based on 23 796 consecutive autopsies World J Gastroenterol 12 2006 2115 2119
3. R. Rajani, T. Melin, E. Bjornsson, Í.U. Broome, P. Sangfelt, and A. Danielsson Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience Liver Int 29 2009 253 259
4. W. Ageno, A. Squizzato, A. Togna, F. Magistrali, M. Mangini, and C. Fugazzola Incidental diagnosis of a deep vein thrombosis in consecutive patients undergoing a computed tomography scan of the abdomen: a retrospective cohort study J Thromb Haemost 10 1 2012 158 160
5. M.R. Thatipelli, R.D. McBane, D.O. Hodge, and W.E. Wysokinski Survival and Recurrence in Patients With Splanchnic Vein Thromboses Clin Gastroenterol Hepatol 8 2010 200 205
6. S. Acosta, A. Alhadad, P. Svensson, and O. Ekberg Epidemiology, risk and prognostic factors in mesenteric venous thrombosis Br J Surg 95 2008 1245 1251
7. B. Condat, and D. Valla Nonmalignant portal vein thrombosis in adults Nat Clin Pract Gastroenterol Hepatol 3 9 2006 505 515
8. V. De Stefano, T. Za, A. Ciminello, S. Betti, and E. Rossi Causes of adult splanchnic vein thrombosis in the mediterranean area Mediterr J Hematol Infect Dis 3 1 2011 e2011063
9. F. Dentali, M. Galli, M. Gianni, and W. Ageno Inherited thrombophilic abnormalities and risk of portal vein thrombosis. a meta-analysis Thromb Haemost 99 2008 675 682
10. V. De Stefano, and I. Martinelli Splanchnic vein thrombosis: clinical presentation, risk factors and treatment Intern Emerg Med 6 2010 487 494
11. R. Kralovics, F. Passamonti, A.S. Buser, S.S. Teo, R. Tiedt, and J.R. Passweg A gain-of-function mutation of JAK2 in myeloproliferative disorders N Engl J Med 352 17 2005 1779 1790
12. D. Colaizzo, L. Amitrano, G.L. Tiscia, G. Scenna, E. Grandone, and M.A. Guardascione The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis J Thromb Haemost 5 1 2007 55 61
13. F. Dentali, A. Squizzato, L. Brivio, L. Appio, L. Campiotti, and M. Crowther JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis Blood 113 2009 5617 5623
14. S.G. Xavier, T. Gadelha, S.M. Rezende, I.R. Zalcberg, and N. Spector JAK2V617F mutation in patients with thrombosis: to screen or not to screen? Int J Lab Hematol 33 2011 117 124
15. C. Parker, M. Omine, S. Richards, J. Nishimura, M. Bessler, and R. Ware International PNH Interest Group. Diagnosis and management of paroxysmal nocturnal hemoglobinuria Blood 106 12 2005 3699 3709
16. J.C. Garcia-Pagán, M. Heydtmann, S. Raffa, A. Plessier, S. Murad, and F. Fabris Budd-Chiari Syndrome-Transjugular Intrahepatic Portosystemic Shunt Group. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients Gastroenterology 135 3 2008 808 815
17. S.T. van Bijnen, W.L. van Heerde, and P. Muus Mechanisms and Clinical Implications of Thrombosis in Paroxysmal Nocturnal Hemoglobinuria J Thromb Haemost 10 1 2012 1 10
18. R. de Franchis, and on behalf of the Baveno V Faculty Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension J Hepatol 53 2010 762 768
19. C. Kearon, E.A. Akl, A.J. Comerota, P. Prandoni, H. Bounameaux, and S.Z. Goldhaber American College of Chest Physicians. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2 Suppl 2012 e419S e494S
20. B. Condat, F. Pessione, S. Hillaire, M.H. Denninger, M.C. Guillin, and M. Poliquin Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy Gastroenterology 120 2001 490 497
21. A. Plessier, S.D. Murad, M. Hernandez-Guerra, Y. Consigny, F. Fabris, and J. Trebicka for the European Network for Vascular Disorders of the Liver (EN-Vie). Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study Hepatology 51 2010 210 218
22. L. Amitrano, M.A. Guardascione, M. Scaglione, L. Pezzullo, N. Sangiuliano, and M.F. Armellino Prognostic factors in noncirrhotic patients with splanchnic vein thromboses Am J Gastroenterol 102 11 2007 2464 2470
23. F. Dentali, W. Ageno, D. Witt, A. Malato, N. Clark, and D. Garcia for the WARPED consortium. Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study Thromb Haemost 102 2009 501 504
24. M. Senzolo, O. Riggio, and M. Primignani on behalf of the Italian Association for the Study of the Liver. Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee Dig Liver Dis 43 2011 503 514
25. H.L. Janssen, J.C. Garcia-Pagan, E. Elias, G. Mentha, A. Hadengue, and D.C. Valla for the European Group for the Study of Vascular Disorders of the Liver. Budd-Chiari syndrome: a review by an expert panel J Hepatol 38 2003 364 371
26. S.D. Darwish-Murad, A. Plessier, M. Hernandez-Guerra, F. Fabris, C.E. Eapen, and M.J. Bahr for EN-Vie (European Network for Vascular Disorders of the Liver). Etiology, management, and outcome of the Budd-Chiari syndrome Ann Intern Med 151 2009 167 175